MedPacto, Inc. (235980.KQ)

KRW 4585.0

(-1.4%)

Total Assets Summary of MedPacto, Inc.

MedPacto, Inc.'s latest annual total assets in 2023 was 80.47 Billion KRW , down -25.27% from previous year.
MedPacto, Inc.'s latest quarterly total assets in 2024 Q2 was 67.09 Billion KRW , down -6.62% from previous quarter.
MedPacto, Inc. reported annual total assets of 107.68 Billion KRW in 2022, down -19.24% from previous year.
MedPacto, Inc. reported annual total assets of 133.34 Billion KRW in 2021, up 127.96% from previous year.
MedPacto, Inc. reported quarterly total assets of 71.84 Billion KRW for 2024 Q1, down -10.72% from previous quarter.
MedPacto, Inc. reported quarterly total assets of 17.17 Billion KRW for 2023 Q3, down -21.84% from previous quarter.

Annual Total Assets Chart of MedPacto, Inc. (2023 - 2017)

Historical Annual Total Assets of MedPacto, Inc. (2023 - 2017)

Year	Total Assets	Total Assets Growth
2023	80.47 Billion KRW	-25.27%
2022	107.68 Billion KRW	-19.24%
2021	133.34 Billion KRW	127.96%
2020	58.49 Billion KRW	-27.51%
2019	80.69 Billion KRW	153.61%
2018	31.82 Billion KRW	2285.19%
2017	1.33 Billion KRW	0.0%

Year	Total Assets	Total Assets Growth
2024 Q2	67.09 Billion KRW	-6.62%
2024 Q1	71.84 Billion KRW	-10.72%
2023 Q3	17.17 Billion KRW	-21.84%
2023 FY	80.47 Billion KRW	-25.27%
2023 Q4	80.47 Billion KRW	368.58%
2023 Q2	21.97 Billion KRW	-27.23%
2023 Q1	30.19 Billion KRW	-71.96%
2022 Q4	107.68 Billion KRW	-10.77%
2022 Q2	123.95 Billion KRW	-2.68%
2022 FY	107.68 Billion KRW	-19.24%
2022 Q1	127.36 Billion KRW	-4.48%
2022 Q3	120.68 Billion KRW	-2.63%
2021 Q4	133.34 Billion KRW	-4.62%
2021 Q1	155.66 Billion KRW	166.11%
2021 Q2	147.94 Billion KRW	-4.96%
2021 FY	133.34 Billion KRW	127.96%
2021 Q3	139.79 Billion KRW	-5.51%
2020 Q4	58.49 Billion KRW	0.0%
2020 FY	58.49 Billion KRW	-27.51%
2019 FY	80.69 Billion KRW	153.61%
2018 FY	31.82 Billion KRW	2285.19%
2017 FY	1.33 Billion KRW	0.0%

Peer Total Assets Comparison of MedPacto, Inc.

Name	Total Assets	Total Assets Difference
HLB Co., Ltd.	751.72 Billion KRW	89.295%
iNtRON Biotechnology, Inc.	98.61 Billion KRW	18.395%
BINEX Co., Ltd.	257.01 Billion KRW	68.688%
Bioneer Corporation	315.48 Billion KRW	74.492%
Anterogen.Co.,Ltd.	149.43 Billion KRW	46.146%
MEDIPOST Co., Ltd.	449.39 Billion KRW	82.093%
CrystalGenomics, Inc.	243.11 Billion USD	66.899%
Helixmith Co., Ltd	227.27 Billion KRW	64.592%
Chabiotech Co.,Ltd.	1725.57 Billion KRW	95.336%
Medy-Tox Inc.	611.62 Billion KRW	86.842%
Peptron, Inc.	52.49 Billion KRW	-53.296%
Amicogen, Inc.	467.09 Billion KRW	82.771%
Genexine, Inc.	376.58 Billion KRW	78.631%
HLB Therapeutics Co.,Ltd.	200.79 Billion KRW	59.922%
LegoChem Biosciences, Inc.	189.5 Billion KRW	57.534%
ALTEOGEN Inc.	256.09 Billion KRW	68.577%
PharmaResearch Co., Ltd.	535.28 Billion KRW	84.966%
SillaJen, Inc.	76.71 Billion KRW	-4.901%
JETEMA, Co., Ltd.	252.14 Billion KRW	68.084%
OliX Pharmaceuticals,Inc	102.82 Billion KRW	21.737%
Genomictree Inc.	132.84 Billion KRW	39.422%
D&D Pharmatech	79.2 Billion KRW	-1.604%
EASY BIO,Inc.	172.04 Billion KRW	53.224%
GI Innovation, Inc.	81.34 Billion KRW	1.064%